SVFCX vs. DOCU, NICE, ESTC, MNDY, TWLO, CYBR, PCOR, GWRE, PAYC, and DUOL
Should you be buying Smead Value C stock or one of its competitors? The main competitors of Smead Value C include DocuSign (DOCU), NICE (NICE), Elastic (ESTC), monday.com (MNDY), Twilio (TWLO), CyberArk Software (CYBR), Procore Technologies (PCOR), Guidewire Software (GWRE), Paycom Software (PAYC), and Duolingo (DUOL).
DocuSign (NASDAQ:DOCU) and Smead Value C (NASDAQ:SVFCX) are both business services companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, analyst recommendations, profitability, institutional ownership, dividends, community ranking, media sentiment and valuation.
DocuSign received 412 more outperform votes than Smead Value C when rated by MarketBeat users. However, 100.00% of users gave Smead Value C an outperform vote while only 59.31% of users gave DocuSign an outperform vote.
DocuSign has a beta of 0.89, suggesting that its stock price is 11% less volatile than the S&P 500. Comparatively, Smead Value C has a beta of 0.11, suggesting that its stock price is 89% less volatile than the S&P 500.
DocuSign has a net margin of 3.81% compared to DocuSign's net margin of 0.00%. Smead Value C's return on equity of 16.06% beat DocuSign's return on equity.
DocuSign currently has a consensus target price of $60.00, suggesting a potential upside of 15.27%. Given Smead Value C's higher probable upside, equities analysts plainly believe DocuSign is more favorable than Smead Value C.
DocuSign has higher revenue and earnings than Smead Value C.
77.6% of DocuSign shares are held by institutional investors. Comparatively, 60.2% of Smead Value C shares are held by institutional investors. 1.7% of DocuSign shares are held by company insiders. Comparatively, 10.3% of Smead Value C shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
In the previous week, DocuSign had 47 more articles in the media than Smead Value C. MarketBeat recorded 47 mentions for DocuSign and 0 mentions for Smead Value C. Smead Value C's average media sentiment score of 0.34 beat DocuSign's score of 0.00 indicating that DocuSign is being referred to more favorably in the media.
Summary
DocuSign beats Smead Value C on 12 of the 14 factors compared between the two stocks.
Get Smead Value C News Delivered to You Automatically
Sign up to receive the latest news and ratings for SVFCX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SVFCX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
SVFCX vs. The Competition
Smead Value C Competitors List
Related Companies and Tools
